午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ShangHai Biochempartner Co.,Ltd

Firmenname:ShangHai Biochempartner Co.,Ltd
Telefon:177-54423994
E-Mail:2853530910@QQ.com
Nationalit?t:China
URL: www.biochempartner.com
Produkte insgesamt:7972

Produktkatalog

Ganitumab905703-97-1
BAY85-85011161921-82-9C22H17F3N4O3S
GV-581402821-41-3C18H26N6OS
Cl-Amidine1043444-18-3C14H19ClN4O2 ? CF3CO2H
PRL-3 Inhibitor I893449-38-2C17H11Br2NO2S2
Sacituzumab1796566-95-4
Tuvirumab138660-97-6
Elinzanetant929046-33-3C33H35F7N4O3
Abemaciclib Metabolites M21231930-57-6C25H28F2N8
Vodobatinib1388803-90-4C27H20ClN3O2
F-9013181928707-56-5C28H27FN6O2
Briakinumab339308-60-0
Tadocizumab339086-80-5
Lumiliximab357613-86-6
SU4984186610-89-9C20H19N3O2
Bavituximab648904-28-3
Basiliximab179045-86-4
Clenoliximab182912-58-9
Ilginatinib1239358-86-1C21H20FN7
Galiximab357613-77-5
JNJ38877605943540-74-7C20H12F2N6
Keliximab174722-30-6
Sulesomab167747-19-5
BMS 9862992242952-69-6C18H19N7O
TL8951415823-49-2C25H26FN5O2
BAY-18308391931994-80-7C22H25F3N4O3
Vimseltinib1628606-05-2C23H25N7O2
M-88911464842-09-8C20H17F2N3O3
Tositumomab208921-02-2
Zabedosertib1931994-81-8C20H21F3N4O4S
Oregovomab213327-37-8
Milatuzumab899796-83-9
Mitumomab216503-58-1
Biciromab138783-13-8
Nofetumomab165942-79-0
Afelimomab156227-98-4
Inolimomab152981-31-2
ABAGOVOMAB792921-10-9
Gavilimomab244096-20-6
Edobacomab141410-98-2
Igovomab171656-50-1
Supinoxin888478-45-3C22H24FN5O4
Otilimab1638332-55-4
CX-16321038984-31-4C20H17FN4O3
Imciromab126132-83-0
ADH-5032055362-72-4C22H15NO4S2
(EZ)-GO289694522-87-7C17H15BrN4O2S
Dynarrestin2222768-84-3C22H23F2N3O2S
ADH-5032055362-74-6C27H29N2O5S2+
Bertilimumab375348-49-5
Tralokinumab1044515-88-9
Fresolimumab948564-73-6
Lerdelimumab285985-06-0
OATD012088453-21-6C19H27ClN6O
Tafenoquine succinate106635-81-8C28H34F3N3O7
Lexatumumab845816-02-6
Mapatumumab658052-09-6
Metelimumab272780-74-2
N-(3-Fluoro-4-methyl-8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide143655-58-7C13H14FNO2
MC-Gly-Gly-Phe1599440-15-9C23H28N4O7
Fmoc-Gly-Gly-Phe-OtBu236426-37-2C32H35N3O6
Lu-AF271392097117-06-9C21H19ClF3N5O2S
Eliapixant1948229-21-7C22H21F3N4O3S
ADX-102916056-79-6C12H13ClN2O
ITI-214(phosphate)1642303-38-5C29H29FN7O5P
Bunamidine HClN,N-Dibutyl-4-(hexyloxy)naphthalin-1-carboximidamidhydrochlorid1055-55-6C25H39ClN2O
RIPA-561956370-21-0C13H19NO2
N-(3-Fluoro-4-methyl-5-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide182182-29-2C13H14FNO2
4-(2-Acetamido-4-fluoro-5-methylphenyl)butanoic acid182182-28-1C13H16FNO3
N,N-(3-Fluoro-4-methyl-8-oxo-5,6,7,8-tetrahydronaphthalene-1,7-diyl)diacetamide143655-70-3C15H17FN2O3
CFI-4018701430741-35-7C30H31N5O2
RAD51-IN-172101739-18-6C22H16ClN3O
CNQX115066-14-3C9H4N4O4
Lefamulin Acetate1350636-82-6C30H49NO7S
RMC-46302172652-48-9C20H27ClN6O2S
LGD-69721207989-09-0C43H46N2O5S
GSK-1520489A1042433-41-9C21H23N5O3S
1A-1161430208-73-3C16H16F3N3
IM1561422365-94-3C15H20F3N5O3
WIN54954107355-45-3C18H20Cl2N2O3
Dimethyl carbate39589-98-5C11H14O4
TeclozanTeclozan5560-78-1C20H28Cl4N2O4
ABT-384868623-40-9C25H34F3N5O2
MEISi-22250156-71-7C18H14N2O3
3,5-Dibromo-4-chloro-1H-pyrazole27258-21-5C3HBr2ClN2
1H-Imidazo[4,5-c]quinolin-4-amine, 1-(4-aminobutoxy)-2-butyl-1359993-63-7C18H25N5O
1,2-Bis(2-chloropyridin-3-yl)diselane1094062-82-4C10H6Cl2N2Se2
Rimcazole dihydrochloride75859-03-9C21H29Cl2N3
(R)-2-(piperazin-2-yl)acetonitrile2250242-65-8C6H11N3
MK2-IN-3 hydrate1186648-22-5C21H18N4O2
PF-068736002185857-97-8C20H27F2N5O4S
1-(sec-butyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole2222997-43-3C13H23BN2O2
PMX205514814-49-4C45H62N10O6
4-Bromo-2-fluoro-3-(trifluoromethyl)aniline159329-03-0C7H4BrF4N
Belzutifan1672668-24-4C17H12F3NO4S
CB-66442316817-88-4C29H34ClFN4O5
4-amino-3-fluoro-2-methoxybenzonitrile1272719-22-8C8H7FN2O
6-(3-(Oxazol-2-yl)propyl)pyridin-3-amine1398048-78-6C11H13N3O
1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 3-[(2-aminoethyl)thio]-6-[(1R)-1-hydroxyethyl]-7-oxo-, (5R,6S)-, (4-nitrophenyl)methyl ester, hydrochloride, compd. with 1-methyl-2-pyrrolidinone1622223-88-4C23H31ClN4O7S
S-Amisulpride71675-92-8C17H27N3O4S
Copyright 2019 ? ChemicalBook. All rights reserved